Invention Grant
- Patent Title: Vaccinia virus polypeptides
- Patent Title (中): 牛痘病毒多肽
-
Application No.: US13593365Application Date: 2012-08-23
-
Publication No.: US09446119B2Publication Date: 2016-09-20
- Inventor: Gregory A. Poland , Richard B. Kennedy
- Applicant: Gregory A. Poland , Richard B. Kennedy
- Applicant Address: US MN Rochester
- Assignee: Mayo Foundation for Medical Education and Research
- Current Assignee: Mayo Foundation for Medical Education and Research
- Current Assignee Address: US MN Rochester
- Agency: Fish & Richardson P.C.
- Main IPC: A61K39/285
- IPC: A61K39/285 ; A61K38/00 ; A61K39/295 ; C12N7/00 ; C12N15/86 ; A61K39/12 ; C07K14/005
Abstract:
This document provides methods and materials related to polypeptides present in a vaccinia virus (e.g., membrane proteins such as vaccinia virus B5R, L1R, A33R, or A27L polypeptides). For example, methods for generating a vaccine comprising one or more of vaccinia virus polypeptides disclosed herein for preventing or treating Orthopoxvirus infection are provided. In addition, kits related to the use of vaccinia polypeptides are provided.
Public/Granted literature
- US20140050752A1 VACCINIA VIRUS POLYPEPTIDES Public/Granted day:2014-02-20
Information query
